A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid Tumors
Clinical trial NCT03946800 · COMPLETED
Trial details
- NCT number
- NCT03946800
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2023-08-24
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.